AI assistant
Sending…
RESMED INC — Director's Dealing 2013
Jan 31, 2013
30071_dirs_2013-01-31_a80abaab-8e13-4dfd-8303-d0dd1049e1b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-01-29
Reporting Person: Farrell Michael J. (President - Americas)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-01-29 | ResMed Common Stock | M | 8000 | $21.025 | Acquired | 94795.806 | Direct |
| 2013-01-29 | ResMed Common Stock | S | 8000 | $47.320 | Disposed | 86795.806 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-29 | ResMed Common Stock Options | $21.025 | M | 8000 | Disposed | 2014-11-07 | ResMed Common Stock (8000) | Direct |
Footnotes
F1: Represents date options first became exercisable.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29